Frontiers in Medicine | Hepatobiliary Diseases

Original Research

Published on 21 Nov 2023

Association between the sarcopenia index and abnormal liver function in the adult population in the United States: a cross-sectional study

in Hepatobiliary Diseases

Jian Xu
Zhi-Xiang Xu
Qi-Fan Yang
Jing Zhuang
Xin Zhu
Jun Yao

Frontiers in Medicine

doi 10.3389/fmed.2023.1266253

5,642 views
7 citations

Original Research

Published on 09 Nov 2023

Association of direct bilirubin to total bilirubin ratio with 90-day mortality in patients with acute-on-chronic liver failure

in Hepatobiliary Diseases

Yuanji Ma
Lingyao Du
Shaoqun Zhou
Lang Bai
Hong Tang

Frontiers in Medicine

doi 10.3389/fmed.2023.1286510

5,731 views
16 citations

Original Research

Published on 06 Nov 2023

Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes

in Hepatobiliary Diseases

Nan Zhu
Yongfeng Song
Chen Zhang
Kai Wang
Junming Han

Frontiers in Medicine

doi 10.3389/fmed.2023.1294425

2,868 views
3 citations

Original Research

Published on 31 Oct 2023

Targeted IFNγ induction by a genetically engineered Salmonella typhimurium is the key to the liver metastasis inhibition in a mouse model of pancreatic neuroendocrine tumor

in Hepatobiliary Diseases

Zhan Hua
Shan Wu
Yulian Zhang
Xiuhong Wang
Ju Cui
Yunxuan Li
Chengcheng Yang
Min Zhai
Bo Deng
Bin Yu

Frontiers in Medicine

doi 10.3389/fmed.2023.1284120

3,000 views
1 citation

Original Research

Published on 23 Oct 2023

Recurrence of common bile duct stones after choledocholithotomy in elderly patients: risk factor analysis and clinical prediction model development

in Hepatobiliary Diseases

Han Wang
Yu-qi He
Shi-yang Dong
Wan Zhong
Ping Tao
Shi-yong Yang
Zi-jun Liu

Frontiers in Medicine

doi 10.3389/fmed.2023.1239902

4,750 views
7 citations

Original Research

Published on 18 Oct 2023

Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics

in Hepatobiliary Diseases

Huan Yang
Yunshan Li
Weihong Xu
Wenjuan Liu
Ying Xie

Frontiers in Medicine

doi 10.3389/fmed.2023.1247851

4,357 views

Original Research

Published on 27 Sep 2023

Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy

in Hepatobiliary Diseases

Si-Wen Dang
Lei Gao
Yu-Jun Li
Ruo Zhang
Jing Xu

Frontiers in Medicine

doi 10.3389/fmed.2023.1216412

2,921 views
6 citations

Case Report

Published on 14 Aug 2023

Fatal acute-on-chronic liver failure following camrelizumab for hepatocellular carcinoma with HBsAg seroclearance: a case report and literature review

in Hepatobiliary Diseases

Fenghui Li
Tao Wang
Fei Tang
Jing Liang

Frontiers in Medicine

doi 10.3389/fmed.2023.1231597

2,992 views
5 citations

Case Report

Published on 05 Jul 2023

Case report: Hepatic inflammatory pseudotumor-like follicular dendritic cell sarcoma: a rare case and review of the literature

in Hepatobiliary Diseases

Shuai Yan
Zhiqiang Yue
Peng Zhang
Liuxia Yuan
Huixuan Wang
Fei Yin
Linglin Ju
Lin Chen
Weihua Cai
Yi Ni

Frontiers in Medicine

doi 10.3389/fmed.2023.1192998

3,488 views
9 citations

417 articles

articles

Association between the sarcopenia index and abnormal liver function in the adult population in the United States: a cross-sectional study

Association of direct bilirubin to total bilirubin ratio with 90-day mortality in patients with acute-on-chronic liver failure

Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes

Targeted IFNγ induction by a genetically engineered Salmonella typhimurium is the key to the liver metastasis inhibition in a mouse model of pancreatic neuroendocrine tumor

Recurrence of common bile duct stones after choledocholithotomy in elderly patients: risk factor analysis and clinical prediction model development

Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics

Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy

Fatal acute-on-chronic liver failure following camrelizumab for hepatocellular carcinoma with HBsAg seroclearance: a case report and literature review

Case report: Hepatic inflammatory pseudotumor-like follicular dendritic cell sarcoma: a rare case and review of the literature